Anavex Life Sciences Corp. (AVXL)
4.855
+0.04
(+0.73%)
USD |
NASDAQ |
Jan 15, 16:00
4.855
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences SG&A Expense (TTM): 13.82M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 214.26M |
| CorMedix, Inc. | 75.56M |
| Verastem, Inc. | 67.48M |
| ADMA Biologics, Inc. | 96.37M |
| Aldeyra Therapeutics, Inc. | 9.186M |